Brief: Somnomed Says FY24 EBITDA Guidance Revised To Between A$0.3 Mln & A$0.8 Mln
24/07/2024 01:19
July 24 (Reuters) - Somnomed Ltd SOM.AX :
* FY24 EBITDA GUIDANCE REVISED UPWARDS TO BETWEEN A$0.3
MILLION TO
A$0.8 MILLION
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million